CA3071804C - Utilisation d’un inhibiteur de kdm1a dans le traitement d’altérations du comportement - Google Patents

Utilisation d’un inhibiteur de kdm1a dans le traitement d’altérations du comportement

Info

Publication number
CA3071804C
CA3071804C CA3071804A CA3071804A CA3071804C CA 3071804 C CA3071804 C CA 3071804C CA 3071804 A CA3071804 A CA 3071804A CA 3071804 A CA3071804 A CA 3071804A CA 3071804 C CA3071804 C CA 3071804C
Authority
CA
Canada
Prior art keywords
cyclopropyl
behavior
trans
compound
social
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3071804A
Other languages
English (en)
Other versions
CA3071804A1 (fr
Inventor
Tamara Maes
David ROTLLANT POZO
Christian Grinan Ferre
Merce PALLAS LLIBERIA
Roser NADAL ALEMANY
Antonio Armario Garcia
Original Assignee
Oryzon Genomics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oryzon Genomics SA filed Critical Oryzon Genomics SA
Priority claimed from PCT/EP2018/071120 external-priority patent/WO2019025588A1/fr
Publication of CA3071804A1 publication Critical patent/CA3071804A1/fr
Application granted granted Critical
Publication of CA3071804C publication Critical patent/CA3071804C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des méthodes de traitement des altérations du comportement faisant appel à des inhibiteurs de KDM1A, en particulier la 5-((((1R,2S)-2-(4-(benzyloxy)phényl)cyclopropyl)amino)méthyl)-1,3,4-oxadiazol-2-amine.
CA3071804A 2017-08-03 2018-08-03 Utilisation d’un inhibiteur de kdm1a dans le traitement d’altérations du comportement Active CA3071804C (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP17382544.9 2017-08-03
EP17382544 2017-08-03
EP17382545.6 2017-08-03
EP17382545 2017-08-03
EP18382299 2018-04-30
EP18382299.8 2018-04-30
PCT/EP2018/071120 WO2019025588A1 (fr) 2017-08-03 2018-08-03 Méthodes de traitement des altérations du comportement

Publications (2)

Publication Number Publication Date
CA3071804A1 CA3071804A1 (fr) 2019-02-07
CA3071804C true CA3071804C (fr) 2026-03-24

Family

ID=

Similar Documents

Publication Publication Date Title
US20240277673A1 (en) Methods of treating behavior alterations
JP2024149602A (ja) 境界性パーソナリティ障害の処置方法
EP3941465B1 (fr) Methodes pour le traitement du trouble du déficit de l'attention et hyperactivité en utilisant un inhibiteur de kdm1a tel que le compose vafidemstat
CA3071804C (fr) Utilisation d’un inhibiteur de kdm1a dans le traitement d’altérations du comportement
HK40122445A (en) Methods of treating behavior alterations
RU2799049C2 (ru) Способы лечения изменений поведения
RU2833298C2 (ru) Способы лечения пограничного расстройства личности
HK40029059A (en) Methods of treating behavior alterations
HK40029059B (en) Methods of treating behavior alterations